Want to see IN:NEOGEN full AI Analyst Report?
NEOGEN Stock Chart & Stats
₹1156.90
₹9.65(0.45%)
At close: 4:00 PM EST
₹1156.90
₹9.65(0.45%)
Day’s Range― - ―
52-Week Range₹978.00 - ₹2,370.00
Previous CloseN/A
Volume22.32K
Average Volume (3M)9.36K
Market Cap
₹57.11B
Enterprise Value₹49.43K
Total Cash (Recent Filing)₹49.50M
Total Debt (Recent Filing)₹13.95B
Price to Earnings (P/E)193.3
Beta1.51
Next Earnings
Jul 24, 2026EPS Estimate
5.14Next Dividend Ex-DateN/A
Dividend Yield0.05%
Share Statistics
EPS (TTM)10.89
Shares Outstanding26,381,674
10 Day Avg. Volume1,157
30 Day Avg. Volume9,357
Financial Highlights & Ratios
PEG Ratio-5.85
Price to Book (P/B)3.59
Price to Sales (P/S)3.40
P/FCF Ratio-3.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)17.96
Revenue Forecast (FY)₹12.28B
Bulls Say, Bears Say
Bulls Say
Multi-year Revenue ExpansionConsistent multi-year top-line growth demonstrates the company can expand volumes and customer penetration across cycles. Durable revenue scale supports better capacity utilization, allows reinvestment in product/quality, and helps absorb fixed costs, strengthening medium-term resilience.
Diversified End-market ExposureExposure to multiple downstream industries reduces reliance on any single cyclical market and stabilizes demand for specialty intermediates. Pharmaceutical and agrochemical customers typically provide repeat orders and contract durability, supporting steadier revenue streams over months to years.
Specialized Chemistry & Manufacturing CapabilitiesTechnical specialization and compliant manufacturing/quality systems are high barriers for new entrants and enable customer-specific qualifying processes. That creates sticky supply relationships, repeat demand for validated grades, and supports long-term product differentiation and margin resilience.
Bears Say
Sharp Margin CompressionA large step-down in gross and net margins signals sustained pricing pressure, adverse mix shifts, or rising input costs that erode profitability. Lower margins reduce retained earnings and the firm’s ability to self-fund growth or cushion against future cost shocks over the medium term.
Material Increase In LeverageThe sharp rise in debt and higher debt-to-equity materially increases interest and refinancing risk. Elevated leverage reduces financial flexibility for capex or working-capital needs and magnifies downside if cash flows or margins deteriorate, raising medium-term funding risk.
Weak Operating And Free Cash FlowDeeply negative operating and free cash flow indicates heavy working-capital strain or large investments not currently covered by operating earnings. Persistent cash burn forces reliance on external financing, constrains sustainable investment and dividend policy, and elevates execution risk over months.
Neogen Chemicals Ltd. News
NEOGEN FAQ
What was Neogen Chemicals Ltd.’s price range in the past 12 months?
Neogen Chemicals Ltd. lowest stock price was ₹978.00 and its highest was ₹2370.00 in the past 12 months.
What is Neogen Chemicals Ltd.’s market cap?
Neogen Chemicals Ltd.’s market cap is ₹57.11B.
When is Neogen Chemicals Ltd.’s upcoming earnings report date?
Neogen Chemicals Ltd.’s upcoming earnings report date is Jul 24, 2026 which is tomorrow.
How were Neogen Chemicals Ltd.’s earnings last quarter?
Neogen Chemicals Ltd. released its earnings results on May 16, 2026. The company reported ₹4.32 earnings per share for the quarter, beating the consensus estimate of ₹2 by ₹2.32.
Is Neogen Chemicals Ltd. overvalued?
According to Wall Street analysts Neogen Chemicals Ltd.’s price is currently Overvalued.
Does Neogen Chemicals Ltd. pay dividends?
Neogen Chemicals Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.05%. See more information on Neogen Chemicals Ltd. dividends here
What is Neogen Chemicals Ltd.’s EPS estimate?
Neogen Chemicals Ltd.’s EPS estimate is 5.14.
How many shares outstanding does Neogen Chemicals Ltd. have?
Neogen Chemicals Ltd. has 26,381,674 shares outstanding.
What happened to Neogen Chemicals Ltd.’s price movement after its last earnings report?
Neogen Chemicals Ltd. reported an EPS of ₹4.32 in its last earnings report, beating expectations of ₹2. Following the earnings report the stock price went down -0.898%.
Which hedge fund is a major shareholder of Neogen Chemicals Ltd.?
Currently, no hedge funds are holding shares in IN:NEOGEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Neogen Chemicals Ltd.
Neogen Chemicals Limited, founded in Thane, India, in 1989, is engaged in the manufacturing and supply of an extensive array of specialized chemical products. The company's comprehensive portfolio encompasses numerous organo-bromine compounds, including alkyl bromides, dibromoalkanes, bromo chloro alkanes, various bromine derivatives (of organoacids, esters, aromatics, and cyclics), and specialty bromo-fluoro derivatives. Additionally, Neogen offers specialty chloro compounds, unsaturated and bromo-hydroxy derivatives, inorganic bromine compounds, lithium salts, Grignard reagents, and advanced intermediates. Beyond its product range, the firm also provides custom synthesis and contract manufacturing services. Neogen's offerings cater to diverse industrial sectors such as pharmaceuticals, agrochemicals, engineering, flavors and fragrances, electronic chemicals, refrigeration, construction, specialty polymers, and heating, ventilation, and air conditioning (HVAC). The company maintains an international presence, exporting its chemicals to 28 nations globally.
Technical Analysis
Alkyl Amines Chemicals Limited
―
Balaji Amines Limited
―
Laxmi Organic Industries Ltd.
―
Tatva Chintan Pharma Chem Limited
―
Vishnu Chemicals Limited
―